TTrialPathMatch Me to Trials
← Back to trials
RecruitingAcute Ischemic Stroke

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

Eligible age

18–79 yrs

Accepts

All genders

Locations

24 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The primary objective is to establish the efficacy of intra-arterial (IA) mechanical thrombectomy (MT) with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patients with acute ischemic stroke (AIS) from intracranial vessel occlusion (IVO) in the anterior circulation and have a proximal carotid occlusive disease (occlusion or severe stenosis).

Sponsor: Mercy Health Ohio

You may qualify if…

  • 1. 18 to 79 years of age (before the 80th birthday)
  • 2. Presenting with symptoms consistent with AIS
  • 3. Imaging evidence of an anterior circulation occlusion of the Internal Carotid Artery (ICA) terminus and/or Middle Cerebral Artery Main Stem (MCA M1), or proximal M2 segment AND extra-cranial proximal carotid occlusion / severe stenosis related to atherosclerosis requiring treatment on non-invasive imaging ≥70%
  • 4. NIHSS ≥ 4
  • 5. Ability to randomize and start endovascular therapy within 16 hours of stroke onset
  • 6. Pre-stroke mRS score 0-2
  • 7. Ability to obtain signed informed consent
  • 8. ASPECTS Score ≥7 via non-contrast CT or MRI (DWI) for subjects ≤6 hours from stroke onset OR ASPECTS Score ≥7 + infarct core volume \<50 cc quantified by CTP (rCBF\<30%) OR \<25 cc quantified by MRI-DWI (AxBxC/2) for subjects with endovascular therapy starting between \>6h to 16 hours from stroke onset, given the need for antiplatelet therapy.

You may not qualify if…

  • 1. Females who are pregnant, or those of child-bearing potential with positive urine or serum beta Human Chorionic Gonadotropin (HCG) test
  • 2. Known severe allergy (more than a rash) to contrast media uncontrolled by medications
  • 3. Refractory hypertension (defined as persistent systolic blood pressure \>185 mmHg or diastolic blood pressure \>110 mmHg) despite medication
  • 4. CT evidence of the following conditions:
  • Midline shift or herniation
  • Evidence of intracranial hemorrhage
  • Mass effect with effacement of the ventricles
  • 5. Acute bilateral strokes

Where it's recruiting

Alabama

Mobile

California

Glendale · Irvine · Pomona · Sacramento

Florida

Boca Raton · Delray Beach · Jacksonville · Miami

Georgia

Atlanta · Marietta

Illinois

Chicago · Winfield

Indiana

Indianapolis · Munster

Kansas

Kansas City

Kentucky

Lexington

Louisiana

New Orleans · Shreveport

Massachusetts

Boston · Worcester

Michigan

Flint · Kalamazoo · Lansing · Mount Clemens

Missouri

St Louis

Source: ClinicalTrials.gov · NCT05611242 · last updated 2025-12-17